Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesics effect on pulpal sensibility in irreversible pulpitis
NCT07125911Completed
- Sponsor
- HITEC Institute of Medical Sciences
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in irreversible pulpitis comparing Ibuprofen 400 mg with Paracetamol 500 mg (2 arms). Primary endpoint: Change in pulpal sensibility test results at 30 months. Started Apr 2024; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07125911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125911.